Replies to post #731525 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

My guess is the following means the achievement of digitized oversight for product release is inevitable and imminent (perhaps completed) now. Because you can’t have one (EDEN eventually certified) without the other (digitized product release), imo.

Note the two dates below.

A draft Statutory instrument was laid in Parliament on 21st October. The legislation aims to transform the manufacture of innovative medicines at the point of care. The UK will be the first country globally to introduce a tailored framework for the regulation of innovative products manufactured at or close to the location where a patient receives care….

….Allow manufacture of innovative medicines in small, portable units that can be set up close to patients who may be unable to travel or where rapid medicine availability is best served….

The legislation proposes a six-month implementation period once Parliamentary processes have been concluded. This regulation could, therefore, become law in Summer 2025.

https://ct.catapult.org.uk/news/regulatory-round-up-october-2024